Artelo Biosciences Announces Proposed Underwritten Public Offering
September 29, 2025 19:15 ET | Source: Artelo Biosciences SOLANA BEACH, Calif.,…
NANOBIOTIX Announces Updated Phase 1 Results Continuing to Support JNJ-1900 (NBTXR3) Plus Anti-PD-1 as a Potential New 1L or 2L+ Option in Anti-PD-1 Nave or Resistant R/M-HNSCC
Treatment remained well-tolerated with consistent injection feasibility in 103 heavily pre-treated patients…
Genmab to Acquire Merus, Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned Model
Company Announcement Genmab to acquire Merus for USD 97.00 per share in…
CLINUVEL to advance novel pharmaceutical formulations in preclinical program
Executive summary first biocompatible pharmaceutical formulations progress to preclinical modelsnew sustained-release drug…
LEQEMBI (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimers Disease Approved in China
September 28, 2025 19:30 ET | Source: Biogen Inc. TOKYO and CAMBRIDGE,…
Glucose Health, Inc. Announces Officer Changes Effective September 30, 2025
September 26, 2025 16:00 ET | Source: Glucose Health BENTONVILLE, Ark., Sept.…
Scilex Holding Company Announces Closing of Previously Announced Initial Tranche Investment in Datavault AI
September 26, 2025 15:57 ET | Source: Scilex Holding Company PALO ALTO,…
Tekton Research Expands Clinical Network with Three New Sites, Five New Investigators, and CNS Thought Leader
AUSTIN, Texas, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Tekton Research, a leading…
Oculis Publishes Notification of Transactions by Person Discharging Managerial Responsibilities
Accessibility: Skip TopNav ZUG, Switzerland, Sept. 26, 2025 (GLOBE NEWSWIRE) -- The…
